Form: SCHEDULE 13G

Statement of Beneficial Ownership by Certain Investors

October 15, 2025






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Shares of Clean Energy Fuels Corp.'s (the "Issuer") common stock, par value $0.0001 (the "Common Stock"), reported herein represent the right of Stonepeak CLNE-W Holdings LP, a Delaware limited partnership ("Stonepeak CLNE-W"), to receive 20,050,618 shares of Common Stock pursuant to that certain warrant agreement, dated as of December 12, 2023, by and among the Issuer and Stonepeak CLNE-W (the "Warrant Agreement"), upon Stonepeak CLNE-W's exercise of certain of the Issuer's warrants issued to Stonepeak CLNE-W pursuant to such Warrant Agreement (the "Warrants"). The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The shares of Common Stock reported herein represent the right of Stonepeak CLNE-W to receive 20,050,618 shares of Common Stock pursuant to the Warrant Agreement upon Stonepeak CLNE-W's exercise of the Warrants issued to Stonepeak CLNE-W thereby. The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The shares of Common Stock reported herein represent the right of Stonepeak CLNE-W to receive 20,050,618 shares of Common Stock pursuant to the Warrant Agreement upon Stonepeak CLNE-W's exercise of the Warrants issued to Stonepeak CLNE-W thereby. The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The shares of Common Stock reported herein represent the right of Stonepeak CLNE-W to receive 20,050,618 shares of Common Stock pursuant to the Warrant Agreement upon Stonepeak CLNE-W's exercise of the Warrants issued to Stonepeak CLNE-W thereby. The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The shares of Common Stock reported herein represent the right of Stonepeak CLNE-W to receive 20,050,618 shares of Common Stock pursuant to the Warrant Agreement upon Stonepeak CLNE-W's exercise of the Warrants issued to Stonepeak CLNE-W thereby. The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The shares of Common Stock reported herein represent the right of Stonepeak CLNE-W to receive 20,050,618 shares of Common Stock pursuant to the Warrant Agreement upon Stonepeak CLNE-W's exercise of the Warrants issued to Stonepeak CLNE-W thereby. The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The shares of Common Stock reported herein represent the right of Stonepeak CLNE-W to receive 20,050,618 shares of Common Stock pursuant to the Warrant Agreement upon Stonepeak CLNE-W's exercise of the Warrants issued to Stonepeak CLNE-W thereby. The Warrants become exercisable by Stonepeak CLNE-W on December 12, 2025 and the amount of Common Stock underlying such Warrants is subject to certain periodic adjustments as more particularly described in the Warrant Agreement. (2) The percentage set forth in Row 11 of this Cover Page is based on (i) the 219,289,216 shares of Common Stock outstanding as of July 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and (ii) the 20,050,618 shares of Common Stock underlying the Warrants as reported herein.


SCHEDULE 13G



 
Stonepeak CLNE-W Holdings LP
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell on behalf of STONEPEAK CLNE-W HOLDINGS LP (1)
Date:10/15/2025
 
Stonepeak Opportunities Fund Associates LP
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell on behalf of STONEPEAK OPPORTUNITIES FUND ASSOCIATES LP (1)
Date:10/15/2025
 
Stonepeak Opportunities Fund GP Investors LP
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell on behalf of STONEPEAK OPPORTUNITIES FUND GP INVESTORS LP (1)
Date:10/15/2025
 
Stonepeak GP Investors Holdings LP
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell on behalf of STONEPEAK GP INVESTORS HOLDINGS LP (1)
Date:10/15/2025
 
Stonepeak GP Investors Upper Holdings LP
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell on behalf of STONEPEAK GP INVESTORS UPPER HOLDINGS LP (1)
Date:10/15/2025
 
Stonepeak GP Investors Holdings Manager LLC
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell on behalf of STONEPEAK GP INVESTORS HOLDINGS MANAGER LLC (1)
Date:10/15/2025
 
Dorrell Michael B.
 
Signature:/s/ Michael B. Dorrell
Name/Title:Michael B. Dorrell
Date:10/15/2025

Comments accompanying signature:  (1) Michael B. Dorrell is the Chairman, Chief Executive Officer and Co-Founder of Stonepeak GP Investors Holdings Manager LLC, the general partner of Stonepeak GP Investors Upper Holdings LP, the general partner of Stonepeak GP Investors Holdings LP, the general partner of Stonepeak Opportunities Fund GP Investors LP, the general partner of Stonepeak Opportunities Fund Associates LP, the general partner of Stonepeak CLNE-W Holdings LP.
Exhibit Information

Exhibit 99.1 Joint Filing Agreement, dated as of October 15, 2025, by and among the Reporting Persons (filed herewith)